was read the article
array:25 [ "pii" => "S2013251416301183" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.01.011" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "207" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2016;36:545-51" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4864 "formatos" => array:3 [ "EPUB" => 346 "HTML" => 3927 "PDF" => 591 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S021169951630039X" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.01.018" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "207" "copyright" => "Sociedad Española de Nefrología" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2016;36:545-51" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7264 "formatos" => array:3 [ "EPUB" => 311 "HTML" => 6005 "PDF" => 948 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "La ingesta elevada de sodio disminuye la respuesta antiproteinúrica del bloqueo del eje renina-angiotensina-aldosterona en el trasplante renal" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "545" "paginaFinal" => "551" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "A high sodium intake reduces antiproteinuric response to renin-angiotensin-aldosterone system blockade in kidney transplant recipients" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1273 "Ancho" => 1560 "Tamanyo" => 73217 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Descenso de la proteinuria en porcentaje por cada tercil de excreción urinaria del cociente sodio/creatinina.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Elena Monfá, Emilio Rodrigo, Lara Belmar, Cristina Sango, Fozi Moussa, Juan Carlos Ruiz San Millán, Celestino Piñera, Gema Fernández-Fresnedo, Manuel Arias" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Elena" "apellidos" => "Monfá" ] 1 => array:2 [ "nombre" => "Emilio" "apellidos" => "Rodrigo" ] 2 => array:2 [ "nombre" => "Lara" "apellidos" => "Belmar" ] 3 => array:2 [ "nombre" => "Cristina" "apellidos" => "Sango" ] 4 => array:2 [ "nombre" => "Fozi" "apellidos" => "Moussa" ] 5 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Ruiz San Millán" ] 6 => array:2 [ "nombre" => "Celestino" "apellidos" => "Piñera" ] 7 => array:2 [ "nombre" => "Gema" "apellidos" => "Fernández-Fresnedo" ] 8 => array:2 [ "nombre" => "Manuel" "apellidos" => "Arias" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251416301183" "doi" => "10.1016/j.nefroe.2016.01.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301183?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951630039X?idApp=UINPBA000064" "url" => "/02116995/0000003600000005/v3_201705130058/S021169951630039X/v3_201705130058/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2013251416301262" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.11.014" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "244" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Nefrologia (English Version). 2016;36:552-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3768 "formatos" => array:3 [ "EPUB" => 365 "HTML" => 2727 "PDF" => 676 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "The need for genetic study to diagnose some cases of distal renal tubular acidosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "552" "paginaFinal" => "555" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Necesidad de estudio genético para el diagnóstico de algunos casos de acidosis tubular renal distal" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1409 "Ancho" => 1417 "Tamanyo" => 180147 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Plain abdominal X-ray with extensive bilateral renal calcifications.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Manuel Heras Benito, Miguel A. Garcia-Gonzalez, María Valdenebro Recio, Álvaro Molina Ordás, Ramiro Callejas Martínez, María Astrid Rodríguez Gómez, Leonardo Calle García, Lisbeth Sousa Silva, María José Fernández-Reyes Luis" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Manuel" "apellidos" => "Heras Benito" ] 1 => array:2 [ "nombre" => "Miguel A." "apellidos" => "Garcia-Gonzalez" ] 2 => array:2 [ "nombre" => "María" "apellidos" => "Valdenebro Recio" ] 3 => array:2 [ "nombre" => "Álvaro" "apellidos" => "Molina Ordás" ] 4 => array:2 [ "nombre" => "Ramiro" "apellidos" => "Callejas Martínez" ] 5 => array:2 [ "nombre" => "María Astrid" "apellidos" => "Rodríguez Gómez" ] 6 => array:2 [ "nombre" => "Leonardo" "apellidos" => "Calle García" ] 7 => array:2 [ "nombre" => "Lisbeth" "apellidos" => "Sousa Silva" ] 8 => array:2 [ "nombre" => "María José" "apellidos" => "Fernández-Reyes Luis" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699516301096" "doi" => "10.1016/j.nefro.2016.06.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301096?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301262?idApp=UINPBA000064" "url" => "/20132514/0000003600000005/v1_201612260003/S2013251416301262/v1_201612260003/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2013251416301250" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.11.013" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "242" "copyright" => "Sociedad Española de Nefrología" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2016;36:535-44" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5579 "formatos" => array:3 [ "EPUB" => 312 "HTML" => 4351 "PDF" => 916 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "535" "paginaFinal" => "544" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Factores predictivos de nefropatía no diabética en pacientes diabéticos. Utilidad de la biopsia renal" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1461 "Ancho" => 1505 "Tamanyo" => 62788 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ROC curve: the model's discriminative ability showed an ROC curve with an area under the curve of 0.805 (95% CI: 0.708–0.902).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sheila Bermejo, María José Soler, Javier Gimeno, Clara Barrios, Eva Rodríguez, Sergi Mojal, Julio Pascual" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Sheila" "apellidos" => "Bermejo" ] 1 => array:2 [ "nombre" => "María José" "apellidos" => "Soler" ] 2 => array:2 [ "nombre" => "Javier" "apellidos" => "Gimeno" ] 3 => array:2 [ "nombre" => "Clara" "apellidos" => "Barrios" ] 4 => array:2 [ "nombre" => "Eva" "apellidos" => "Rodríguez" ] 5 => array:2 [ "nombre" => "Sergi" "apellidos" => "Mojal" ] 6 => array:2 [ "nombre" => "Julio" "apellidos" => "Pascual" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699516301072" "doi" => "10.1016/j.nefro.2016.06.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301072?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301250?idApp=UINPBA000064" "url" => "/20132514/0000003600000005/v1_201612260003/S2013251416301250/v1_201612260003/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "545" "paginaFinal" => "551" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Elena Monfá, Emilio Rodrigo, Lara Belmar, Cristina Sango, Fozi Moussa, Juan Carlos Ruiz San Millán, Celestino Piñera, Gema Fernández-Fresnedo, Manuel Arias" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Elena" "apellidos" => "Monfá" ] 1 => array:4 [ "nombre" => "Emilio" "apellidos" => "Rodrigo" "email" => array:1 [ 0 => "nefrce@humv.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:2 [ "nombre" => "Lara" "apellidos" => "Belmar" ] 3 => array:2 [ "nombre" => "Cristina" "apellidos" => "Sango" ] 4 => array:2 [ "nombre" => "Fozi" "apellidos" => "Moussa" ] 5 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Ruiz San Millán" ] 6 => array:2 [ "nombre" => "Celestino" "apellidos" => "Piñera" ] 7 => array:2 [ "nombre" => "Gema" "apellidos" => "Fernández-Fresnedo" ] 8 => array:2 [ "nombre" => "Manuel" "apellidos" => "Arias" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander (Cantabria), Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La ingesta elevada de sodio disminuye la respuesta antiproteinúrica del bloqueo del eje renina-angiotensina-aldosterona en el trasplante renal" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1273 "Ancho" => 1560 "Tamanyo" => 69260 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Percentage decrease in proteinuria for each tertile of urinary sodium/creatinine ratio.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The development of proteinuria, even in a small amount, after kidney transplantation is associated with a reduction in graft and patient survival, and so the control of proteinuria is of clinical relevance.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">1–3</span></a> Unfortunately, a large number of kidney transplant recipients develop proteinuria. In a study of 613 kidney transplants, up to 45% had proteinuria of more than 150<span class="elsevierStyleHsp" style=""></span>mg/day, and in 65% of these patients proteinuria was below 500<span class="elsevierStyleHsp" style=""></span>mg/day. Biopsies from patients with proteinuria showed mainly interstitial fibrosis and tubular atrophy, or non-specific findings, except in those with proteinuria above 1500<span class="elsevierStyleHsp" style=""></span>mg/day, in which glomerular involvement was predominant.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">4</span></a> The factors inducing the onset of proteinuria include: transplant from a female donor to a male recipient; advanced donor age; kidney function; blood pressure; cell rejection and antibody-mediated rejection; recurrence of glomerulonephritis; prolonged warm and cold ischaemia; and delayed initiation of graft function.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">4–6</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The measures currently used to reduce post-transplant proteinuria include strict control of blood pressure, renin–angiotensin–aldosterone system (RAAS) blockade with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor II blockers (ARBs), lipid control, stop smoking and maintaining a healthy weight.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">7</span></a> Specifically, the KDIGO guidelines recommend using ACE inhibitors or ARBs in patients with recurrent glomerulonephritis and proteinuria and in hypertensive patients with proteinuria ≥1<span class="elsevierStyleHsp" style=""></span>g/day.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">8</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">In the general population, RAAS blockade has been shown to be effective in reducing proteinuria, controlling hypertension and reducing the progression of chronic kidney disease (CKD) in patients with diabetic and non-diabetic nephropathy.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">9,10</span></a> Although some studies have demonstrated the efficacy of the antiproteinuric effect of RAAS blockade in kidney transplantation,<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">11,12</span></a> there is no precise information on the efficacy of proteinuria reduction on preservation of renal function and improvement of graft and patient survival.<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">12–16</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In non-transplant CKD patients, several factors can reduce the antiproteinuric effect of RAAS blockade.<a class="elsevierStyleCrossRefs" href="#bib0285"><span class="elsevierStyleSup">17–22</span></a> Salt intake is one of these factors. One meta-analysis that included 11 studies was able to quantify that albuminuria was decreased by 32.1% for every reduction in sodium intake of 92<span class="elsevierStyleHsp" style=""></span>mEq/day.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">22</span></a> None of the cohorts considered in the meta-analysis included kidney transplant patients. The aim of our study was to assess the relationship between sodium intake and the antiproteinuric effect of ACE inhibitors and ARBs in our population of kidney transplant patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Study population and design</span><p id="par0025" class="elsevierStylePara elsevierViewall">We selected 137 patients from a population of 1423 kidney transplants performed at our site between October 1986 and May 2012. Patients included were those: (1) who have been transplanted for more than 3 months (2) had proteinuria greater than 1<span class="elsevierStyleHsp" style=""></span>g/day; (3) who had been treated with ACE inhibitors or ARBs for more than 6 months; and (4) had a urinary sodium/creatinine ratio value available before starting treatment with ACE inhibitors or ARBs. We excluded 34 patients with changes in plasma creatinine greater than 25% before starting ACE inhibitors or ARBs, and patients who had modified their diuretic therapy in the month before starting ACE inhibitors or ARBs or over the 6 months of follow-up. In our unit, all patients are trained to perform an accurate collection of a 24-h urine protein test in each routine visit, and all receive specific dietary advice to follow a diet low in fat and salt. A total of 40 patients (38.8%) were on diuretic therapy. The doses of ACE inhibitors and ARBs were standardised for an equivalent dose of enalapril according to previous drug guidelines and studies on the antiproteinuric effect with equivalent doses.<a class="elsevierStyleCrossRefs" href="#bib0315"><span class="elsevierStyleSup">23–25</span></a> The study was conducted in accordance with the criteria set forth in the Declaration of Helsinki.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Data collection</span><p id="par0030" class="elsevierStylePara elsevierViewall">The patient characteristics and laboratory data were collected at the beginning of the RAAS blockade and at 6 months (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>), and they were extracted prospectively from the database of kidney transplant patients from our site. The variables collected were ages of the donor and recipient, weight, cause of CKD, cause of proteinuria, immunosuppressive drugs, time since transplant at the beginning of the RAAS blockade and laboratory data. Proteinuria was determined by the pyrogallol red-molybdate (PRM) method for the 24-h urine protein test. Sodium intake was estimated by 24-h urinary sodium excretion and normalised with creatinine with the sodium/creatinine ratio to avoid possible errors in the collection. Blood pressure was measured 3 times, separated by 5<span class="elsevierStyleHsp" style=""></span>min by an automatic system, and the final reading was used.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Statistical analysis</span><p id="par0035" class="elsevierStylePara elsevierViewall">Categorical variables were expressed as relative frequencies and continuous variables as the mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation, except for those who had normal distribution, which were reported as median and interquartile range (IQR). Tertiles for the urinary sodium/creatinine ratio were established, and salt intake was estimated (<87<span class="elsevierStyleHsp" style=""></span>mEq/g; between 87 and 138<span class="elsevierStyleHsp" style=""></span>mEq/g; >138<span class="elsevierStyleHsp" style=""></span>mEq/g; cut-offs of 87 and 138<span class="elsevierStyleHsp" style=""></span>mEq/g are equivalent to 6.4 and 9.4<span class="elsevierStyleHsp" style=""></span>g of salt per day). Proteinuria, urinary sodium/creatinine ratio, creatinine clearance in urine, kidney function and serum potassium were compared at baseline and at 6 months using the Student's <span class="elsevierStyleItalic">t</span>-test for paired samples. The relationship between quantitative variables was analysed by correlation analysis. The Kruskal–Wallis test was used to establish the relationship between the percentage of decrease in proteinuria and the tertiles of urinary sodium/creatinine ratio. Inadequate antiproteinuric response was defined as a percentage of reduction in proteinuria of less than 50%. The risk factors for inadequate antiproteinuric response were analysed using the Student's <span class="elsevierStyleItalic">t</span>-test, Mann–Whitney <span class="elsevierStyleItalic">U</span> test and Chi-squared test. A multivariate logistic regression analysis was conducted with all significant variables. A <span class="elsevierStyleItalic">p</span>-value <5% was considered statistically significant. SPSS version 15.0 (SPSS Inc., Chicago, IL, USA) was used to perform the analysis.</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><p id="par0040" class="elsevierStylePara elsevierViewall">Patient characteristics at baseline and at 6 months are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. In all, 55.4% of patients received ACE inhibitors and 44.6%, ARBs. Six months after starting the RAAS blockade, serum creatinine and potassium levels increased, systolic and diastolic BP decreased, and 24-h proteinuria was significantly reduced (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). By contrast, there were no significant differences at 6 months in urinary sodium or creatinine elimination, nor in urinary sodium/creatinine ratio (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). In 46 patients (44.7%) proteinuria was reduced below one gram after 6 months of RAAS blockade. We found no significant differences in the initial sodium/creatinine ratio amongst patients with and without diuretic treatment (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.083).</p><p id="par0045" class="elsevierStylePara elsevierViewall">A high urinary sodium/creatinine ratio was associated with a smaller reduction in proteinuria at 6 months (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.251; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.011) and a lower percentage of decreased proteinuria from baseline proteinuria (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.211; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.033). Similarly, the percentage of reduction in proteinuria from baseline was significantly lower in patients in the highest tertile for the urinary sodium/creatinine ratio [63.9% (IQR 47.1%); 60.1% (IQR 55.4%); 38.9% (IQR 85.5%); <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.047] (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). The decrease in the absolute value for proteinuria at 6 months was lower for the highest tertile, but was not statistically significant [1161<span class="elsevierStyleHsp" style=""></span>mg (IQR 2406<span class="elsevierStyleHsp" style=""></span>mg); 978<span class="elsevierStyleHsp" style=""></span>mg (IQR 1299<span class="elsevierStyleHsp" style=""></span>mg); 696<span class="elsevierStyleHsp" style=""></span>mg (IQR 1422<span class="elsevierStyleHsp" style=""></span>mg); <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.056].</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a> shows the factors that are in relation with a percent reduction of in proteinuria of less than 50% (52 patients). The use of mTOR inhibitors and a lower urinary sodium/creatinine ratio was significantly related to a reduction in proteinuria greater than 50%. Neither serum creatinine nor glomerular filtration rate were associated with the percent decreased in proteinuria (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>) or reduction of proteinuria in absolute values (data not shown). The doses of ACE inhibitors and ARBs standardised for enalapril were not associated with the decreased in proteinuria (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.149). Using a logistic regression analysis, including the significant variables (use of mTOR inhibitors and sodium/creatinine ratio), the urinary sodium/creatinine ratio was the only factor related independently (OR 2.406 by 100<span class="elsevierStyleHsp" style=""></span>mEq/g, 95% CI: 1.008–5.745; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.048) to an inadequate antiproteinuric response after RAAS blockade in kidney transplant recipients.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Discussion</span><p id="par0055" class="elsevierStylePara elsevierViewall">As in previous studies in transplant and non-transplant patients,<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">9,26</span></a> we have observed that RAAS blockers significantly reduce proteinuria. After 6 months of treatment, mean proteinuria was reduced from 3.6 to 2.2<span class="elsevierStyleHsp" style=""></span>g/day, and in almost half of patients (44.7%) proteinuria fell below 1<span class="elsevierStyleHsp" style=""></span>g/day. The advantages of the use of ACE inhibitors/ARBs in kidney transplants remain controversial, with studies where there is no histological improvement, and no change in graft or patient survival, or in the cardiovascular risk<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">15,16,27</span></a>; others studies show an increase in patient survival, but not in the graft survival<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">28</span></a>; and there are also studies showing an improvement in both graft and patient survival.<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">29</span></a> In this latter study, the greatest benefit on graft outcome was observed in patients with higher proteinuria.<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">29</span></a> Whether due to a specific effect of RAAS blockade, or not, what is clear is that the reduction of short-term albuminuria has a long-term nephroprotective effect.</p><p id="par0060" class="elsevierStylePara elsevierViewall">In a meta-analysis of 21 clinical trials that included 78,342 patients, Heerspink et al. observed that for every 30% reduction in albuminuria achieved with RAAS blockade, the risk to reach stage 5 CKD was reduced by 32% in the long term analysis.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">30</span></a> The reduction of approximately 39% in proteinuria observed in our study with RAAS blockers may lead to a reduction in the loss of long-term renal grafts of more than 30%, although this effect should be evaluated in long-term studies. In contrast to the general population, in the kidney transplant population the reduction of proteinuria with ACE inhibitors/ARBs has not been demonstrated to be reduce the progression of renal disease. This may be due to the characteristics of the transplant patients (i.e. immunosuppressive therapy, especially with calcineurin inhibitors and alloimmune damage) as well as to methodological problems. For example, in the meta-analysis by Heerspink et al., a sample size of less than 1250 patient or the cause of the nephropathy affected the ability of the studies to show any benefit from RAAS blockade.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">30</span></a> In kidney transplantation it is difficult to conduct long-term studies with large numbers of patients enough to demonstrate the long-term benefit of ACE inhibitors and ARBs.</p><p id="par0065" class="elsevierStylePara elsevierViewall">The effect of low-salt diet on BP is recognised both in the transplant population as well as in the general population.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">31</span></a> However, many patients with CKD have a salt intake above the WHO recommendations (below 5<span class="elsevierStyleHsp" style=""></span>g/day).<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">32</span></a> Amongst kidney transplant recipients, up to 87% have a urinary sodium excretion that reflects a salt intake above 5<span class="elsevierStyleHsp" style=""></span>g. In addition, salt intake is maintained over time in each patient and in the overall population, despite the recommendations made.<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">31,33,34</span></a> This suggests that, despite some difficulties, we have an opportunity to improve outcomes in kidney transplant recipients by intensifying dietary measures without requiring drug.</p><p id="par0070" class="elsevierStylePara elsevierViewall">The main finding of our study is that a high-salt diet limits the antiproteinuric effect of ACE inhibitors and ARBs in the kidney transplant population, similar to previously published studies of CKD patients. In a prospective study of 500 non-diabetic patients with CKD, Vegter et al. showed that patients in the highest tertile of urinary sodium/creatinine ratio showed a minor decrease in proteinuria with ramipril (20%) compared with patients with lower salt intake (25% and 31%), leading to an increased risk of developing stage 5 CKD.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">17</span></a> In our kidney transplant patients the percent reduction in proteinuria in the different tertiles of sodium/creatinine ratio (from to the highest to the lowest) was 16%, 41% and 43%, respectively. The antiproteinuric effect of low-salt diet has been proven to be more effective even than double RAAS blockade, or as effective as diuretic therapy.<a class="elsevierStyleCrossRefs" href="#bib0290"><span class="elsevierStyleSup">18,20</span></a> Thus, in a randomised study of 52 patients with non-diabetic nephropathy, the reduction in proteinuria caused by adding a low-salt diet to treatment with ACE inhibitors was significantly greater than the reduction of proteinuria by adding ARBs to ACE inhibitors (51% vs. 21%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001).<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">18</span></a> Also in 34 patients with proteinuria without diabetes, in whom treatment with losartan decreased proteinuria by 30%, the addition of hydrochlorothiazide achieved a reduction of 56%, and of 55% by adding a low-salt diet.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">20</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Therefore, it seems advisable to insist that the transplant patients also must follow a diet low in salt, especially in those with proteinuria who have not responded, or responded only partially, with RAAS blockade. Given the differences between the highest tertile for salt intake and the middle and lower tertiles in our study, we recommend at least a moderate decrease in sodium intake to improve the antiproteinuric response to treatment with ACE inhibitors/ARBs, without requiring a severe restriction. It is foreseeable that, in parallel to that observed in the non-transplant CKD population, a greater reduction in proteinuria will contribute to improving renal graft survival.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The pathophysiological mechanisms that contribute to the antiproteinuric effect of salt restriction are not fully known. In normal conditions, salt intake is associated with an increase in serum sodium that triggers the thirst centre and stimulates the secretion of antidiuretic hormone. All this leads to increased blood volume, blood pressure and glomerular filtration rate. This decreases the activating stimulus of renin, which makes RAAS blockade less effective for hypertension and proteinuria. If serum sodium decreases, blood volume and blood pressure are also reduced; the RAAS blockade is activated and becomes more effective.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">22</span></a> Furthermore, sodium appears to play a role through the endothelium. Verhave et al. showed that salt intake increases albuminuria independently of blood pressure,<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">35</span></a> a fact that reflects the specific endothelial damage. We also found a relationship between changes in blood pressure and antiproteinuric response, a finding previously described by some authors and which suggests that the reduction in proteinuria induced by salt restriction is influenced both by intraglomerular pressure and systemic BP.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">17</span></a> This endothelial damage could also be mediated by inflammatory mechanisms: it has even been observed that high salt intake is associated with higher albuminuria and with elevated CRP in hypertensive patients.<a class="elsevierStyleCrossRefs" href="#bib0310"><span class="elsevierStyleSup">22,36</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Analysing the factors that could be related to the antiproteinuric response, we noted that the use of mTOR inhibitors is associated with a greater antiproteinuric response to ACE inhibitors/ARBs, although this finding was not confirmed in the multivariate analysis. The use of ACE inhibitors/ARBs has been shown to be effective in the literature in treating and even preventing proteinuria that develops after conversion from calcineurin inhibitors to mTOR inhibitors.<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">37</span></a> Several mechanisms have been described that contribute to the onset of proteinuria with mTOR inhibitors. Most times proteinuria develops after discontinuation of calcineurin inhibitors, probably related to the interruption of their vasoconstrictor effect.<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">38,39</span></a> There are some assumptions that point to possible direct glomerular and tubular damage and there have been reported cases of focal and segmental glomerulosclerosis.<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">39,40</span></a> There are no specific studies demonstrating a better antiproteinuric response with ACE inhibitors/ARBs in patients treated with mTOR inhibitors. To explain our findings, we can speculate with 2 potential mechanisms: (1) ACE inhibitors and ARBs reduce glomerular capillary pressure that would increase after the withdrawal of calcineurin inhibitors and beginning the mTOR inhibitor; and 92) both ACE inhibitors and ARBs reverse the damage mediated by angiotensin II, specifically induced by mTOR on albumin uptake in the proximal tubule.<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">40</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">The main limitation of our study is that it is an observational study in which patients are on different drugs and different ACE inhibitors and ARBs. However, it does reflect routine clinical practice in that the doses are adjusted according to potassium, creatinine and BP. There were no different antiproteinuric responses seen when normalising to a standard dose of enalapril, which can be explained because most patients were on 5<span class="elsevierStyleHsp" style=""></span>mg of enalapril and the same dose was maintained throughout the study period (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). As discussed above, the absence of a relationship between changes in BP and the antiproteinuric effect of salt restriction indicates that low-salt diet exerts its additional antiproteinuric effect through partially independent mechanisms of lower BP and doses of ACE inhibitors/ARBs. A second limitation is that this is a single-centre study, with a limited sample size. However, the significant relationship between urinary sodium/creatinine ratio and antiproteinuric response indicates that there is an association between them. There need to be larger, multicentre, prospective studies to confirm the role of sodium intake in the antiproteinuric response to RAAS blockade in renal transplant patients.</p><p id="par0095" class="elsevierStylePara elsevierViewall">In conclusion, our study indicates that, in renal transplant patients with proteinuria treated with ACE inhibitors/ARBs, high salt intake is associated with a smaller decrease in proteinuria and possibly with lower graft survival. Avoiding excessive salt intake is a necessary and effective measure that should be combined with RAAS blockade.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflicts of interest</span><p id="par0100" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres782004" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec781214" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres782003" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec781215" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study population and design" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Data collection" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Statistical analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0030" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0035" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0040" "titulo" => "Conflicts of interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-11-16" "fechaAceptado" => "2016-01-28" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec781214" "palabras" => array:6 [ 0 => "Angiotensin" 1 => "Angiotensin II receptor blocker" 2 => "Angiotensin-converting-enzyme inhibitor" 3 => "Proteinuria" 4 => "Renin" 5 => "Kidney transplantation" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec781215" "palabras" => array:6 [ 0 => "Angiotensina" 1 => "Antagonistas del receptor de angiotensina" 2 => "Inhibidores de la enzima convertidora de angiotensina" 3 => "Proteinuria" 4 => "Renina" 5 => "Trasplante renal" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Post-transplant proteinuria is associated with lower graft and patient survival. Renin–angiotensin–aldosterone system blockers are used to reduce proteinuria and improve renal outcome. Although it is known that a high salt intake blunts the antiproteinuric effect of ACEI and ARB drugs in non-transplant patients, this effect has not been studied in kidney transplant recipients.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To analyse the relationship between sodium intake and the antiproteinuric effect of ACEI/ARB drugs in kidney transplant recipients.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">We selected 103 kidney transplant recipients receiving ACEI/ARB drugs for more than 6 months due to proteinuria >1<span class="elsevierStyleHsp" style=""></span>g/day. Proteinuria was analysed at baseline and at 6 months after starting ACEI/ARB treatment. Salt intake was estimated by urinary sodium to creatinine ratio (uNa/Cr).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Proteinuria fell to less than 1<span class="elsevierStyleHsp" style=""></span>g/day in 46 patients (44.7%). High uNa/Cr was associated with a smaller proteinuria decrease (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.251, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.011). The percentage of proteinuria reduction was significantly lower in patients in the highest uNa/Cr tertile [63.9% (IQR 47.1%), 60.1% (IQR 55.4%), 38.9% (IQR 85.5%), <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.047]. High uNa/Cr independently relates (OR 2.406 per 100<span class="elsevierStyleHsp" style=""></span>mEq/g, 95% CI: 1.008–5.745, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.048) to an antiproteinuric response <50% after renin–angiotensin–aldosterone system blockade.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">A high salt intake results in a smaller proteinuria decrease in kidney transplant recipients with proteinuria treated with ACEI/ARB drugs.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Antecedentes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La proteinuria postrasplante renal se asocia a una disminución en la supervivencia del injerto y del paciente. Para reducir la proteinuria y mejorar el pronóstico renal se recomienda asociar fármacos bloqueantes del sistema renina-angiotensina-aldosterona (RAA). Aunque en los pacientes no trasplantados se ha demostrado que la dieta rica en sal reduce el efecto antiproteinúrico de los IECA y ARA-II, este efecto no se ha estudiado en los trasplantados renales.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivo</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Valorar la relación entre la ingesta de sodio y el efecto antiproteinúrico de los IECA/ARA-II en los trasplantados renales.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Métodos</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Seleccionamos a 103 trasplantados tratados con IECA/ARA-II más de 6 meses por proteinuria > 1 g/día. La proteinuria se analizó al inicio del tratamiento y a los 6 meses. La ingesta de sal se estimó con el cociente urinario sodio/creatinina (uNa/Cr).</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">En 46 pacientes (44,7%) la proteinuria disminuyó < 1 g/día. Un uNa/Cr elevado se relaciona con un menor descenso de la proteinuria (r = −0,251; p = 0,011). El porcentaje de reducción de la proteinuria fue significativamente menor en los pacientes en el tercil más alto de uNa/Cr [63,9% (RIC 47,1%); 60,1% (RIC 55,4%); 38,9% (RIC 85,5%); p = 0,047]. Un uNa/Cr elevado se relaciona de forma independiente (OR 2,406 por 100 mEq/g; IC 95%: 1,008–5,745; p = 0,048) a una respuesta antiproteinúrica < 50% tras el bloqueo del eje RAA.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">En los trasplantados renales con proteinuria tratados con IECA/ARA-II una ingesta elevada de sal se asocia con un menor descenso de la proteinuria.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Monfá E, Rodrigo E, Belmar L, Sango C, Moussa F, Ruiz San Millán JC, et al. La ingesta elevada de sodio disminuye la respuesta antiproteinúrica del bloqueo del eje renina-angiotensina-aldosterona en el trasplante renal. Nefrología. 2016;36:545–551.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1273 "Ancho" => 1560 "Tamanyo" => 69260 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Percentage decrease in proteinuria for each tertile of urinary sodium/creatinine ratio.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">ARBs: angiotensin receptor antagonists; CKD: chronic kidney disease; IFTA: interstitial fibrosis and tubular atrophy; ACE inhibitors: angiotensin-converting enzyme inhibitors; mTOR: mammalian target of rapamycin; IQR: interquartile range; BP: blood pressure.</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">The standard deviation is shown in parentheses.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Baseline \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">6 months \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Recipient's age (years)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">51 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Recipient's gender (male) (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">80.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Weight (kg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">75 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">75 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.064 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Cause of CKD (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Diabetes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Glomerulonephritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">44.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Vascular/nephroangiosclerosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Donor's age (years)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">42 (17) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Serum creatinine (mg/dL)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.16 (0.76) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.42 (1.31) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.012 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Glomerular filtration rate (ml/min/1.73</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">m</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">2</span></span><span class="elsevierStyleItalic">)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">37 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35 (16) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.003 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Potassium (mEq/L)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.2 (0.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.5 (0.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.000 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Systolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">141 (17) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">135 (16) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.000 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Diastolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">83 (11) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">78 (9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.000 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Urinary sodium/creatinine ratio (mEq/g)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">113 (48) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">113 (50) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.940 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Urinary creatinine (mg/day)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1528 (650) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1469 (519) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.205 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Proteinuria (mg/day)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2200 (IQR 3378) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1284 (IQR 2196) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.000 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Proteinuria less than 1</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">g (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Cause of proteinuria (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Glomerular involvement \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>IFTA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>mTOR inhibitors \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Unknown \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">ACE inhibitors/ARBs (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">44.6/55.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Calcineurin inhibitors (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">85.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Azathioprine (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Mycophenolate (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">61.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">mTOR inhibitors (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">18.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Time from transplant to start of ACE inhibitor/ARB (days)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1097 (IQR 2363) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1299514.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Patient characteristics at baseline and at 6 months.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">ARBs: angiotensin receptor antagonists; IFTA: interstitial fibrosis and tubular atrophy; ACE inhibitors: angiotensin-converting enzyme inhibitors; mTOR: mammalian target of rapamycin; IQR: interquartile range; BP: blood pressure.</p><p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">The standard deviation is shown in parentheses.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Percentage<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>50%<br>(<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>53) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Percentage<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>50%<br>(<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>50) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Recipient's age (years)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">48 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">53 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.068 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Recipient's gender (male) (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">84.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">76.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.253 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Weight (kg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">76 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">74 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.367 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Donor's age (years)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">40 (19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44 (15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.237 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Creatinine (mg/dL)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.22 (0.79) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.10 (0.74) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.425 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Glomerular filtration rate (ml/min/1.73</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">m</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">2</span></span><span class="elsevierStyleItalic">)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">37 (15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">38 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.917 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Baseline systolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">140 (19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">142 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.556 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Baseline diastolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">83 (10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">82 (12) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.663 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Systolic BP at 6 months (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">132 (15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">137 (17) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.219 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Diastolic BP at 6 months (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">78 (7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">78 (11) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.938 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Decreased systolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.9 (16.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.7 (17.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.415 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Decreased diastolic BP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.6 (9.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.2 (11.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.534 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Baseline urinary sodium/creatinine ratio (mEq/g)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">103 (43) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">124 (51) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.029 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Third tertile urinary sodium/creatinine ratio (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.114 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Urinary sodium/creatinine ratio at 6 months (mEq/g)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">103 (39) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">123 (58) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.045 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleItalic">Cause of proteinuria (%)</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Glomerular involvement \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">30.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.287 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>IFTA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">69.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>mTOR inhibitors \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Unknown \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Use of mTOR inhibitors \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">26.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.032 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Normalised enalapril dose (%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.149 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>2.5<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 (0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>5<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24 (48) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">31 (58.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18 (36) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (32.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>20<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (9.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 (0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>40<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 (0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Time from transplant to start of ACE inhibitor/ARB (days)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1097 (IQR 2630) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1111 (IQR 1874) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.444 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1299513.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Risk factors related to a percentage decrease in proteinuria of greater than 50%.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:40 [ 0 => array:3 [ "identificador" => "bib0205" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The risk of cardiovascular disease associated with proteinuria in renal transplant patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Fernández-Fresnedo" 1 => "R. Escallada" 2 => "E. Rodrigo" 3 => "A.L. De Francisco" 4 => "J.G. Cotorruelo" 5 => "S. Sanz de Castro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Transplantation" "fecha" => "2002" "volumen" => "73" "paginaInicial" => "1345" "paginaFinal" => "1348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11981434" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816301237" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0210" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G.A. Knoll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2009.06.031" "Revista" => array:5 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2009" "volumen" => "54" "paginaInicial" => "1131" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19726115" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0215" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystatin C and albuminuria as predictors of long-term allograft outcomes in kidney transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Rodrigo" 1 => "J.C. Ruiz" 2 => "G. Fernández-Fresnedo" 3 => "M.D. Fernández" 4 => "C. Piñera" 5 => "R. Palomar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ctr.12082" "Revista" => array:6 [ "tituloSerie" => "Clin Transplant" "fecha" => "2013" "volumen" => "27" "paginaInicial" => "E177" "paginaFinal" => "E183" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23373671" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0220" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proteinuria after kidney transplantation, relationship to allograft histology and survival" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H. Amer" 1 => "M.E. Fidler" 2 => "M. Myslak" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2007.02006.x" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "2748" "paginaFinal" => "2756" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17941956" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0225" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Halimi" 1 => "I. Laouad" 2 => "M. Buchler" 3 => "A. Al-Najjar" 4 => "V. Chatelet" 5 => "T.S. Houssaini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2005.01020.x" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2005" "volumen" => "5" "paginaInicial" => "2281" "paginaFinal" => "2288" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16095510" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0230" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early proteinuria in renal transplant recipients treated with cyclosporin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.P. Fontan" 1 => "A. Rodriguez-Carmona" 2 => "F.T. Garcia" 3 => "F. Valdes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Transplantation" "fecha" => "1999" "volumen" => "67" "paginaInicial" => "561" "paginaFinal" => "568" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10071028" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0235" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Significance and management of proteinuria in kidney transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Amer" 1 => "F. Cosio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2008091005" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2009" "volumen" => "20" "paginaInicial" => "2490" "paginaFinal" => "2492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19820126" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0240" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "KDIGO clinical practice guideline for the care of kidney transplant recipients" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Kidney Disease Improving Global Outcomes (KDIGO) Transplant Work Group" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2009.02886.x" "Revista" => array:7 [ "tituloSerie" => "Am J Transplant" "fecha" => "2009" "volumen" => "9" "numero" => "Suppl. 3" "paginaInicial" => "S1" "paginaFinal" => "S155" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20070667" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0245" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition. A patient-level meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Jafar" 1 => "P. Stark" 2 => "C. Schmid" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2003" "volumen" => "139" "paginaInicial" => "244" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12965979" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1474442215003130" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0250" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E.J. Lewis" 1 => "L.G. Hunsicker" 2 => "R.P. Bain" 3 => "R.D. Rohde" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199311113292004" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1993" "volumen" => "329" "paginaInicial" => "1456" "paginaFinal" => "1462" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8413456" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0255" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Hiremath" 1 => "D. Fergusson" 2 => "S. Doucette" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2007.01928.x" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "2350" "paginaFinal" => "2360" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17845569" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0260" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Philipp" 1 => "F. Martinez" 2 => "H. Geiger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfp581" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2010" "volumen" => "25" "paginaInicial" => "967" "paginaFinal" => "976" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19887503" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0265" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Inigo" 1 => "J.M. Campistol" 2 => "R. Saracho" 3 => "D. Del Castillo" 4 => "F. Anaya" 5 => "N. Esforzado" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nephron Clin Pract" "fecha" => "2003" "volumen" => "95" "paginaInicial" => "84" "paginaFinal" => "90" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0270" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Heinze" 1 => "C. Mitterbauer" 2 => "H. Regele" 3 => "R. Kramar" 4 => "W.C. Winkelmayer" 5 => "G.C. Curhan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2005090955" "Revista" => array:7 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2006" "volumen" => "17" "paginaInicial" => "889" "paginaFinal" => "899" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16481415" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816301201" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0275" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G. Opelz" 1 => "M. Zeier" 2 => "G. Laux" 3 => "C. Morath" 4 => "B. Dohler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2006050543" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2006" "volumen" => "17" "paginaInicial" => "3257" "paginaFinal" => "3262" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17035607" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0280" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Angiotensin II blockade in kidney transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.N. Ibrahim" 1 => "S. Jackson" 2 => "J. Connaire" 3 => "A. Matas" 4 => "A. Ney" 5 => "B. Najafian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2012080777" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2013" "volumen" => "24" "paginaInicial" => "320" "paginaFinal" => "327" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23308016" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0285" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sodium intake, ACE inhibition, and progression to ESRD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Vegter" 1 => "A. Perna" 2 => "M.J. Postma" 3 => "G. Navis" 4 => "G. Remuzzi" 5 => "P. Ruggenenti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Soc Neprhol" "fecha" => "2012" "volumen" => "23" "paginaInicial" => "165" "paginaFinal" => "173" "itemHostRev" => array:3 [ "pii" => "S2211034816300888" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0290" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nephrology Study Group: moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.C. Slagman" 1 => "F. Waanders" 2 => "M.H. Hemmelder" 3 => "A.J. Woittiez" 4 => "W.M. Janssen" 5 => "H.J. Lambers Heerspink" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2011" "volumen" => "343" "paginaInicial" => "4366" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0295" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A low-sodium diet potentiates the effects of losartan in type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.A. Houlihan" 1 => "T.J. Allen" 2 => "A.L. Baxter" 3 => "S. Panangiotopoulos" 4 => "D.J. Casley" 5 => "M.E. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Diabetes Care" "fecha" => "2002" "volumen" => "25" "paginaInicial" => "663" "paginaFinal" => "671" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11919122" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1474442214700286" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0300" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L. Vogt" 1 => "F. Waanders" 2 => "F. Boomsma" 3 => "D. de Zeeuw" 4 => "G. Navis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2007060693" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2008" "volumen" => "19" "paginaInicial" => "999" "paginaFinal" => "1007" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18272844" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0305" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inluencia de los genotipos del sistema renina-angiotensina en la respuesta antiproteinúrica a dosis altas de olmesartán en nefropatías proteinúricas no diabéticas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Goyache-Goñi" 1 => "P. Aranda-Lara" 2 => "A. Reyes-Engels" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nefrología" "fecha" => "2013" "volumen" => "33" "paginaInicial" => "771" "paginaFinal" => "778" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0310" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis of the effect of dietary sodium restriction with or without concomitant renin–angiotensin–aldosterone system-inhibiting treatment on albuminuria" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. D’Elia" 1 => "G. Rossi" 2 => "M. Schiano di Cola" 3 => "I. Savino" 4 => "F. Galletti" 5 => "P. Strazzullo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.09110914" "Revista" => array:7 [ "tituloSerie" => "Clin J Am Soc Nephrol" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "1542" "paginaFinal" => "1552" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26240299" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816301006" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0315" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Matchar" 1 => "D. McCrory" 2 => "L. Orlando" 3 => "M.R. Patel" 4 => "U.D. Patel" 5 => "M.B. Patwardhan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2008" "volumen" => "148" "paginaInicial" => "16" "paginaFinal" => "29" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17984484" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0320" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin–angiotensin system on proteinuria in renal disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Kunz" 1 => "C. Friedrich" 2 => "M. Wolbers" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Inter Med" "fecha" => "2008" "volumen" => "148" "paginaInicial" => "30" "paginaFinal" => "48" "itemHostRev" => array:3 [ "pii" => "S0022510X11700077" "estado" => "S300" "issn" => "0022510X" ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0325" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of dual blockade of the renin–angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Fernández-Juarez" 1 => "J. Luño" 2 => "V. Barrio" 3 => "S.G. de Vinuesa" 4 => "M. Praga" 5 => "M. Goicoechea" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2012.07.011" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2013" "volumen" => "61" "paginaInicial" => "211" "paginaFinal" => "218" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22939518" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0330" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of ACEIs versus ARBs on proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Xu" 1 => "S. Sun" 2 => "Y. Huo" 3 => "L. Yun" 4 => "S. Huang" 5 => "G. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Medicine (Baltimore)" "fecha" => "2015" "volumen" => "94" "paginaInicial" => "e1560" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0335" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular death in kidney recipients treated with renin–angiotensin system blockers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Opelz" 1 => "B. Döhler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.TP.0000437672.78716.28" "Revista" => array:6 [ "tituloSerie" => "Transplantation" "fecha" => "2014" "volumen" => "97" "paginaInicial" => "310" "paginaFinal" => "315" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24492421" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0340" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renin–angiotensin system blockade and kidney transplantation: a longitudinal cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Hernández" 1 => "A. Muriel" 2 => "V. Abraira" 3 => "G. Pérez" 4 => "E. Porrini" 5 => "D. Marrero" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfr276" "Revista" => array:7 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2012" "volumen" => "27" "paginaInicial" => "417" "paginaFinal" => "422" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21622985" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816301262" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0345" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[Epub ahead of print]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The association between renin–angiotensin system blockade and long-term outcomes in renal transplant recipients: the Wisconsin Allograft Recipient Database (WisARD)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.I. Shin" 1 => "M. Palta" 2 => "A. Djamali" 3 => "D.B. Kaufman" 4 => "B.C. Astor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Transplantation" "fecha" => "2015" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0350" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium. Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.J. Heerspink" 1 => "T.F. Kröpelin" 2 => "J. Hoekman" 3 => "D. de Zeeuw" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2014070688" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2015" "volumen" => "26" "paginaInicial" => "2055" "paginaFinal" => "2064" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25421558" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0355" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sodium excretion pattern at 1 year after kidney transplantation and high blood pressure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Rodrigo" 1 => "E. Monfá" 2 => "Z. Albines" 3 => "M. Serrano" 4 => "G. Fernandez-Fresnedo" 5 => "J.C. Ruiz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.12659/AOT.893862" "Revista" => array:6 [ "tituloSerie" => "Ann Transplant" "fecha" => "2015" "volumen" => "20" "paginaInicial" => "569" "paginaFinal" => "575" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26400681" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0360" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "WHO Forum on Reducing Salt Intake in Populations. Reducing salt intake in populations: report of a WHO forum and technical meeting, 5–7 October 2006, París, Francía. WHO Library Cataloguing-in-Publication Data. Available in: <a id="intr0010" class="elsevierStyleInterRef" href="http://www.who.int/dietphysicalactivity/reducingsaltintake_EN.pdf,%20accessed%20at%20May/2013">http://www.who.int/dietphysicalactivity/reducingsaltintake_EN.pdf, accessed at May/2013</a> [accessed 15.05.13]." ] ] ] 32 => array:3 [ "identificador" => "bib0365" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sodium intake and blood pressure in renal transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Van den Berg" 1 => "J.M. Geleijnse" 2 => "E.J. Brink" 3 => "M.A. van Baak" 4 => "J.J. Homan van der Heide" 5 => "R.O. Gans" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfs069" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2012" "volumen" => "27" "paginaInicial" => "3352" "paginaFinal" => "3359" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22499024" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0370" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Saint-Remy" 1 => "M. Somja" 2 => "K. Gellner" 3 => "L. Weekers" 4 => "C. Bonvoisin" 5 => "J.M. Krzesinski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2369-13-121" "Revista" => array:6 [ "tituloSerie" => "BMC Nephrol" "fecha" => "2012" "volumen" => "13" "paginaInicial" => "121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23013269" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816301067" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0375" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sodium intake affects urinary albumin excretion specially in overweight subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Verhave" 1 => "H.L. Hillege" 2 => "J.G. Burgerhof" 3 => "W.M. Janssen" 4 => "R.T. Gansevoort" 5 => "G.J. Navis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Int Med" "fecha" => "2004" "volumen" => "256" "paginaInicial" => "324" "paginaFinal" => "330" "itemHostRev" => array:3 [ "pii" => "S221103481630116X" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0380" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Yilmaz" 1 => "H. Akoglu" 2 => "B. Altun" 3 => "T. Yildirim" 4 => "M. Arici" 5 => "Y. Erdem" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ejcn.2012.110" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Nutr" "fecha" => "2012" "volumen" => "66" "paginaInicial" => "1214" "paginaFinal" => "1218" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22909578" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0385" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of ramipril on urinary protein excretion in maintenance renal transplant patients converted to sirolimus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.A. Mandelbrot" 1 => "J. Alberú" 2 => "A. Barama" 3 => "B.A. Marder" 4 => "H.T. Silva Jr." 5 => "S.M. Flechner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ajt.13384" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2015" "volumen" => "15" "paginaInicial" => "3174" "paginaFinal" => "3184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26176342" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0390" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is proteinuria reversible after withdrawal of mammalian target of rapamycin inhibitors?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Arnau" 1 => "J.C. Ruiz" 2 => "E. Rodrigo" 3 => "J.A. Quintanar" 4 => "M. Arias" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2011.06.045" "Revista" => array:7 [ "tituloSerie" => "Transplant Proc" "fecha" => "2011" "volumen" => "43" "paginaInicial" => "2194" "paginaFinal" => "2195" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21839231" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S2211034816300992" "estado" => "S300" "issn" => "22110348" ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0395" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "mToR inhibitors-induced proteinuria: mechanisms, significance, and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Leatherier" 1 => "C. Legendre" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Transplant Rev (Orlando)" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "125" "paginaFinal" => "130" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0400" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "mTOR inhibitor-associated proteinuria in kidney transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Diekmann" 1 => "A. Andrés" 2 => "F. Oppenheimer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Transplant Rev" "fecha" => "2012" "volumen" => "26" "paginaInicial" => "27" "paginaFinal" => "29" "itemHostRev" => array:3 [ "pii" => "S1474442214703059" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003600000005/v1_201612260003/S2013251416301183/v1_201612260003/en/main.assets" "Apartado" => array:4 [ "identificador" => "42660" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003600000005/v1_201612260003/S2013251416301183/v1_201612260003/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301183?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 5 | 7 |
2024 October | 46 | 53 | 99 |
2024 September | 42 | 42 | 84 |
2024 August | 58 | 64 | 122 |
2024 July | 27 | 31 | 58 |
2024 June | 49 | 28 | 77 |
2024 May | 46 | 30 | 76 |
2024 April | 46 | 30 | 76 |
2024 March | 38 | 23 | 61 |
2024 February | 27 | 30 | 57 |
2024 January | 22 | 20 | 42 |
2023 December | 17 | 29 | 46 |
2023 November | 39 | 36 | 75 |
2023 October | 27 | 30 | 57 |
2023 September | 18 | 27 | 45 |
2023 August | 36 | 22 | 58 |
2023 July | 30 | 20 | 50 |
2023 June | 37 | 24 | 61 |
2023 May | 38 | 28 | 66 |
2023 April | 35 | 15 | 50 |
2023 March | 53 | 21 | 74 |
2023 February | 40 | 19 | 59 |
2023 January | 34 | 22 | 56 |
2022 December | 57 | 31 | 88 |
2022 November | 52 | 24 | 76 |
2022 October | 54 | 50 | 104 |
2022 September | 55 | 35 | 90 |
2022 August | 53 | 48 | 101 |
2022 July | 27 | 43 | 70 |
2022 June | 38 | 38 | 76 |
2022 May | 51 | 39 | 90 |
2022 April | 48 | 42 | 90 |
2022 March | 53 | 46 | 99 |
2022 February | 48 | 41 | 89 |
2022 January | 32 | 33 | 65 |
2021 December | 49 | 41 | 90 |
2021 November | 40 | 40 | 80 |
2021 October | 45 | 40 | 85 |
2021 September | 29 | 38 | 67 |
2021 August | 31 | 44 | 75 |
2021 July | 37 | 36 | 73 |
2021 June | 56 | 29 | 85 |
2021 May | 40 | 42 | 82 |
2021 April | 88 | 59 | 147 |
2021 March | 54 | 44 | 98 |
2021 February | 36 | 20 | 56 |
2021 January | 41 | 27 | 68 |
2020 December | 32 | 15 | 47 |
2020 November | 41 | 16 | 57 |
2020 October | 28 | 23 | 51 |
2020 September | 40 | 17 | 57 |
2020 August | 60 | 22 | 82 |
2020 July | 39 | 11 | 50 |
2020 June | 35 | 11 | 46 |
2020 May | 44 | 11 | 55 |
2020 April | 32 | 19 | 51 |
2020 March | 46 | 30 | 76 |
2020 February | 57 | 23 | 80 |
2020 January | 47 | 22 | 69 |
2019 December | 69 | 38 | 107 |
2019 November | 42 | 16 | 58 |
2019 October | 34 | 15 | 49 |
2019 September | 36 | 12 | 48 |
2019 August | 39 | 13 | 52 |
2019 July | 31 | 23 | 54 |
2019 June | 63 | 20 | 83 |
2019 May | 63 | 21 | 84 |
2019 April | 86 | 38 | 124 |
2019 March | 47 | 21 | 68 |
2019 February | 31 | 15 | 46 |
2019 January | 47 | 23 | 70 |
2018 December | 228 | 40 | 268 |
2018 November | 490 | 18 | 508 |
2018 October | 427 | 27 | 454 |
2018 September | 197 | 10 | 207 |
2018 August | 155 | 17 | 172 |
2018 July | 56 | 16 | 72 |
2018 June | 61 | 13 | 74 |
2018 May | 90 | 15 | 105 |
2018 April | 152 | 15 | 167 |
2018 March | 131 | 10 | 141 |
2018 February | 261 | 13 | 274 |
2018 January | 266 | 5 | 271 |
2017 December | 285 | 7 | 292 |
2017 November | 92 | 13 | 105 |
2017 October | 39 | 7 | 46 |
2017 September | 55 | 12 | 67 |
2017 August | 29 | 9 | 38 |
2017 July | 25 | 5 | 30 |
2017 June | 37 | 10 | 47 |
2017 May | 40 | 4 | 44 |
2017 April | 45 | 6 | 51 |
2017 March | 22 | 7 | 29 |
2017 February | 29 | 8 | 37 |
2017 January | 46 | 10 | 56 |
2016 December | 9 | 3 | 12 |